Ken Finney

• Partner

  BSc (Hons) PhD Grad Dip Ind Prop FIPTA
  Patent and Trade Marks Attorney,
  Australia and New Zealand

  Ken is a partner at Cullens where he leads the biotechnology group. With almost twenty years
  experience as an IP professional, he acts for both local and overseas clients, including major
  biotechnology and pharmaceutical companies.

  Professional Affiliations

  • Fellow, Institute of Patent and Trade Mark Attorneys of Australia (IPTA)
  • Member, AusBiotech (the Australian Biotechnology Association) (ABA)

  Experience

  • Four years post-doctoral research in the United States (monoclonal antibody production, enzyme
    purification and gene cloning)
  • Four years as a research scientist/senior research scientist with CSIRO (production of
    recombinant animal vaccines)
  • IP professional since 1990
  • Joined Cullens in 1993 and partner since 1999

  Expertise

  • Biotechnology (monoclonal antibodies and recombinant vaccines in particular)
  • Chemical engineering, particularly waste treatment
  • Pharmaceuticals and therapeutic compounds
  • Mechanical devices and machines

• Representative US Patents

  • Patent No. 5,525,231 for “Method of operating a sequencing batch reactor”
  • Patent No. 5,992,356 for “Opposed piston combustion engine”
  • Patent No. 6,221,594 B1 for “Aquatic nitrite oxidising microorganisms of the genus Nitrospira”
  • Patent No. 6,391,639 B1 for “Plant and viral promoters”
  • Patent No. 6,832,559 B2 for “Roller Rail Clamp”
  • Patent No. 7,067,624 B2 for “Antimicrobial Proteins”
  • Patent No. 7,316,084 B2 for “Track Sledding Machine”

  Representative Australian Patent Oppositions

  (acting for the opponent)

  • Application No. 670637 (claims found invalid; reported at 51 IPR 222-256)
  • Application No. 679795 (application withdrawn)
  • Application No. 693795 (claims amended)

• Click here to view Ken’s Profile in PDF format.

  Email  k.finney@cullens.com.au

  Download Ken’s vCard

•